Detalhe da pesquisa
1.
Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.
Mol Cell Biochem
; 375(1-2): 207-17, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23238872
2.
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo.
Transl Oncol
; 15(1): 101301, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890968
3.
2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.
Mol Cancer Res
; 6(9): 1507-20, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18819937
4.
Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
Environ Health Perspect
; 115(11): 1646-53, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18007998
5.
The influence of matriptase-2 on prostate cancer in vitro: a possible role for ß-catenin.
Oncol Rep
; 28(4): 1491-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22858929
6.
Type II transmembrane serine protease (TTSP) deregulation in cancer.
Front Biosci (Landmark Ed)
; 16(2): 539-52, 2011 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21196187
7.
The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
Anticancer Agents Med Chem
; 10(1): 64-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20015002